ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0744

Age and Sex Influence on Clinical Manifestations of Giant Cell Arteritis: Results from the ARTESER Registry

Delia Fernandez-Lozano1, Marta Domínguez-Álvaro2, Javier Narváez3, Noemí Garrido4, Eugenio de Miguel5, Paula Estrada-Alarcón6, Iñigo Hernández-Rodríguez7, Maite Silva-Diaz8, Joaquín M Belzunegui9, Clara Moriano10, Julio Sánchez Martín11, Itziar Calvo-Zorrilla12, Vicente Aldasoro Cáceres13, lydia Abasolo Alcazar14, Javier Loricera15, rafeal Benito-Melero16, Maria Garcia-Villanueva17, Fernando Sánchez-Alonso2, Santos Castañeda18, José L. Hernández19 and Ricardo Blanco20, 1Hospital Universitario y Politecnico La Fe, Valencia, Spain, 2Sociedad Española de Reumatología, Madrid, Spain, 3Hospital Universitario de Bellvitge, Barcelona, Spain, 4Hospital Universitario Virgen del Rocío, Sevilla, Andalucia, Spain, 5Hospital Universitario La Paz, Madrid, Spain, 6Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 7Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 8Complexo Hospitalario Universitario A Coruña, A Coruña, Galicia, Spain, 9Hospital Universitario Donostia, San Sebastian, Spain, 10Hospital León, LEON, Castilla y Leon, Spain, 11Hospital Universitario 12 de Octubre, Madrid, Spain, 12Galdakao-Usansolo University Hospital, Bilbao, Spain, 13Hospital Universitario de Navarra, Pamplona, Spain, 14IdISSC. HCSC, Madrid, Madrid, Spain, 15Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 16MD, barcelona, Spain, 17Hospital Ramón y Cajal, Madrid, Spain, 18Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Madrid, Spain, 19Instituto de Investigación Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain, 20Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain

Meeting: ACR Convergence 2025

Keywords: Demographics, gender, giant cell arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0731–0764) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Giant cell arteritis (GCA) is a large vessel vasculitis that predominantly affects older adults, with a higher prevalence in women. Previous studies exploring sex-related differences in clinical presentation have shown disparate results. The aim of this study was to analyze whether there are differences in the clinical presentation of GCA between men and women, stratified by age at diagnosis.

Methods: ARTESER is a large Spanish multicenter epidemiological registry of GCA promoted by the Spanish Society of Rheumatology (SER*) in which 26 general hospitals participated. The recruitment period was between June 2013 and March 2019. Standardized data were included for all patients diagnosed with GCA in these centers, including demographic and clinical presentation. Age was artificially grouped into three categories (< 70, 70–80, and >80 years) to reflect the most frequent age range of presentation and to optimize the visualization of clinical patterns. This grouping also accounted for the relatively small number of patients in the youngest and oldest age groups. Differences between sexes were compared in a bivariate analysis. Statistical analysis was performed by using STATA statistical package, V.13.1 and SPSS version 21.0.

Results: A total of 1,675 patients with GCA were included in the study, of whom 1,178 were women and 497 men. Among patients younger than 70 years, men presented more frequently with visual symptoms (33.0% vs. 21.7%; p=0.038) and stroke events (7.7% vs. 1.9%; p=0.015) compared to women. In the 70-80 years group, men had a higher frequency of stroke (6.2% vs. 2.3%; p=0.013), dysphagia (7.2% vs. 2.5%; p=0.005), and transient ischaemic attacks (3.6% vs. 1.0%; p=0.024), whereas women showed a greater prevalence of polymyalgia rheumatica (46.3% vs. 33.0%; p=0.003). Weight loss was also more common among men (41.2% vs. 28.2%; p=0.001). No significant sex-based differences were observed in patients aged over 80 years. Results are shown in Table 1.

Conclusion: Sex-related differences in the clinical presentation of GCA were mainly observed in patients diagnosed before the age of 80. Men showed a higher frequency of cranial ischemic manifestations, such as visual symptoms and stroke, whereas women more frequently presented with polymyalgia rheumatica. These findings highlight the importance of considering both sex and age at diagnosis when assessing patients with suspected GCA.

Supporting image 1Table 1: Clinical manifestations between sexes according to age at diagnosis.


Disclosures: D. Fernandez-Lozano: None; M. Domínguez-Álvaro: None; J. Narváez: None; N. Garrido: None; E. de Miguel: AbbVie, 1, 5, 6, BMS, 6, Eli Lilly, 1, 6, Grunenthal, 6, Janssen, 1, 6, MSD, 6, Novartis, 1, 5, 6, Pfizer, 1, 5, 6, Roche, 5, 6, Sanofi, 6, UCB, 6; P. Estrada-Alarcón: None; I. Hernández-Rodríguez: None; M. Silva-Diaz: None; J. Belzunegui: None; C. Moriano: None; J. Sánchez Martín: None; I. Calvo-Zorrilla: None; V. Aldasoro Cáceres: None; l. Abasolo Alcazar: None; J. Loricera: AbbVie/Abbott, 5, AstraZeneca, 2, 5, 6, Celgene, 2, 5, 6, Eli Lilly, 5, Janssen, 5, Merck/MSD, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 5, Roche, 2, 5, 6, UCB, 2, 5, 6; r. Benito-Melero: AbbVie/Abbott, 2, 6, Celgene, 2, 6, Eli Lilly, 2, 6, Merck/MSD, 2, 6, Novartis, 2, 6, Pfizer, 2, 6, Roche, 2, 6; M. Garcia-Villanueva: None; F. Sánchez-Alonso: None; S. Castañeda: None; J. Hernández: None; R. Blanco: AbbVie/Abbott, 2, 5, 6, Bristol-Myers Squibb(BMS), 2, 6, Eli Lilly, 2, 6, Janssen, 2, 6, Merck/MSD, 2, 5, 6, Pfizer, 2, 6, Roche, 2, 5, 6.

To cite this abstract in AMA style:

Fernandez-Lozano D, Domínguez-Álvaro M, Narváez J, Garrido N, de Miguel E, Estrada-Alarcón P, Hernández-Rodríguez I, Silva-Diaz M, Belzunegui J, Moriano C, Sánchez Martín J, Calvo-Zorrilla I, Aldasoro Cáceres V, Abasolo Alcazar l, Loricera J, Benito-Melero r, Garcia-Villanueva M, Sánchez-Alonso F, Castañeda S, Hernández J, Blanco R. Age and Sex Influence on Clinical Manifestations of Giant Cell Arteritis: Results from the ARTESER Registry [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/age-and-sex-influence-on-clinical-manifestations-of-giant-cell-arteritis-results-from-the-arteser-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-and-sex-influence-on-clinical-manifestations-of-giant-cell-arteritis-results-from-the-arteser-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology